0001410442-17-000008.txt : 20170711
0001410442-17-000008.hdr.sgml : 20170711
20170711200344
ACCESSION NUMBER: 0001410442-17-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170707
FILED AS OF DATE: 20170711
DATE AS OF CHANGE: 20170711
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jain Vivek
CENTRAL INDEX KEY: 0001410442
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 17960794
MAIL ADDRESS:
STREET 1: ICU MEDICAL, INC.
STREET 2: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2017-07-07
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001410442
Jain Vivek
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
1
1
0
0
Chairman and CEO
Common Stock
2017-07-07
4
X
0
69014
58.79
A
110925
D
Common Stock
2017-07-07
4
S
0
40046
170.5273
D
70879
D
Common Stock
2017-07-07
4
S
0
19114
171.2198
D
51765
D
Common Stock
2017-07-07
4
S
0
9854
173.2203
D
41911
D
Common Stock
2017-07-10
4
X
0
3704
58.79
A
45615
D
Common Stock
2017-07-10
4
S
0
3704
171.0
D
41911
D
Common Stock
2017-07-11
4
X
0
27282
58.79
A
69193
D
Common Stock
2017-07-11
4
S
0
27282
170.0
D
41911
D
Non-Qualified Stock Option (right to buy)
58.79
2017-07-07
4
X
0
69014
58.79
D
2024-02-24
Common Stock
69014
613352
D
Non-Qualified Stock Option (right to buy)
58.79
2017-07-10
4
X
0
3704
58.79
D
2024-02-24
Common Stock
3704
609648
D
Non-Qualified Stock Option (right to buy)
58.79
2017-07-11
4
X
0
27282
58.79
D
2024-02-24
Common Stock
27282
582366
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.00 to $170.95, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $171.00 to $171.75, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.50 to $173.35, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
All shares sold were sold at the exact price disclosed.
Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days.
Transaction is the exercise of a derivative security; see Column 2.
By: Paula Darbyshire, Attorney-in-fact For: Vivek Jain
2017-07-11